Class / Patent application number | Description | Number of patent applications / Date published |
534015000 | Rare earth containing (At. No. 21, 39, 57-60 or 62-71) | 54 |
20080269470 | Bridged Bi-Aromatic Ligands, Catalysts, Processes For Polymerizing And Polymers Therefrom - New ligands and compositions with bridged bis-aromatic ligands are disclosed that catalyze the polymerization of monomers into polymers. These catalysts with metal centers have high performance characteristics, including higher comonomer incorporation into ethylene/olefin copolymers, where such olefins are for example, 1-octene, propylene or styrene. The catalysts also polymerize propylene into isotactic polypropylene. | 10-30-2008 |
20080306250 | RARE-EARTH AMIDATE CHELATES - The invention is directed to a composition having a lanthanide chelate being a lanthanide and a ligand wherein the ligand is represented by the formula | 12-11-2008 |
20080306251 | RARE-EARTH AMIDATE COORDINATION COMPOUNDS - The invention is directed to a lanthamide chelate composition having a lanthamide, a charged amidate ligand, and a mono- or bidentate neutrally charged coordination compound, the composition being represented by structure I or structure II | 12-11-2008 |
20090012276 | Polyhydroxy Hydrogensulfated Trimetallic Nitride Endohedral Metallofullerenes - Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferably trivalent metals including lanthanides, rare earths or HIB group metals, polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes with properties not found in empty-cage polyhydroxy hydrogensulated fullerenes. | 01-08-2009 |
20090131642 | Synthetic Nanopores for DNA Sequencing - A compound and methods of making thereof having the structure shown below is disclosed. Each Ar is an aromatic group. Each M is palladium, platinum, or rhenium. At least one X in the compound has an aliphatic having at least 1 carbon atom. Each x, each y, and each z is an integer greater than or equal to zero. Each m is an integer greater than or equal to one. n is an integer greater than or equal to three. | 05-21-2009 |
20090192301 | METHOD FOR SYNTHESIZING RARE-EARTH OXO ISOPROPOXIDE - Provided is a method for synthesizing a rare-earth oxo isopropoxide safely with a high yield, using a rare-earth metal, which is more inexpensive than anhydrous rare-earth chlorides, as a raw material. | 07-30-2009 |
20090240042 | ENDOHEDRAL METALLOFULLERENE DERIVATIVES - Trimetallic nitride endohedral metallofullerene derivatives and their preparation are described. The trimetallic nitride endohedral metallofullerene derivatives have the general formula A | 09-24-2009 |
20090247736 | Luminous Compound Containing Lanthanide Ion - A luminous compound represented by the following formula (I): | 10-01-2009 |
20090281290 | Pyridine-bis (oxazoline)("pybox") moiety as a chelator and sensitizer for lanthanide Ion (Ln (III)) luminescence - This invention relates to novel Ln(III) complexes of pybox, and methods of making the same. The present invention also relates to a method of use of pybox as a chelating moiety and sensitizer for Ln(III) ion luminescence. Derivatives of pybox and methods of making the same are also provided. | 11-12-2009 |
20090281291 | IMAGING MEMBERS - Methods for preparing phthalocyanine pigments having a high surface area are provided. | 11-12-2009 |
20090326207 | Gamma Ray-sensitive Phthalocyanine Compound of Poly Cross-linking Type and Ink Composition Comprising The Same - The present invention relates to phthalocyanine compound of poly cross-linking type which is represented with the below formula 1 and is useful for preventing forgery and alternation due to a rapid velocity being responded to a gamma ray of Neutron, and an ink composition comprising it. | 12-31-2009 |
20100069618 | PROCESS FOR PREPARING MATERIALS BY GRAFTING HALOGENATED PHOSPHORUS-CONTAINING GROUPS ONTO AN INORGANIC SURFACE - The invention concerns a process for preparing a hybrid organic-inorganic material (HOIM) with phosphorus-containing bridges between the surface of an inorganic substrate containing an element M and one or more organic groups of the covalent M-O-P-R type, said process using, as a precursor for said organic group or groups, at least one organophosphorus acid halide with formula R | 03-18-2010 |
20100105883 | PENTALENES - The present invention relates to per-substituted pentalene compounds, including permethylpentalene and precursors thereof. In particular, the invention provides substituted pentalene compounds and methods of preparing substituted pentalene compounds; complexes of metals with substituted pentalene compounds and methods for their production; and the use of complexes of metals with substituted pentalene compounds in catalysis. | 04-29-2010 |
20100168404 | Metal Complex Compositions and Methods for Making Metal-Containing Films - The present invention provides compositions of matter useful as deposition agents for making structures, including thin film structures and hard coatings, on substrates and features of substrates. In an embodiment, for example, the present invention provides metal complexes having one or more diboranamide or diboranaphosphide ligands that are useful as chemical vapor deposition (CVD) and/or atomic layer deposition (ALD) precusors for making thin film structures and coatings. Metal complex CVD precursors are provided that possess volitilities sufficiently high so as to provide dense, smooth and homogenous thin films and coatings. | 07-01-2010 |
20100324273 | COMPOUNDS, COMPLEXES AND USES THEREOF - The present application relates to compounds of formulae I and II: | 12-23-2010 |
20110003979 | NEAR INFRARED HIGH EMISSION RARE-EARTH COMPLEX - The present invention has been created to provide a near infrared high emission rare-earth complex having an excellent light-emitting property in the near infrared region. The near infrared high emission rare-earth complex of the present invention is characterized in that its structure is expressed by the following general formula (1): | 01-06-2011 |
20110124848 | METALLOFULLERENE CONTRAST AGENTS - Endohedral metallofullerene compounds, which in water has a relaxivity of about 30 mM | 05-26-2011 |
20110184156 | PRECURSORS FOR DEPOSITION OF METAL OXIDE LAYERS OR FILMS - Rare earth metal precursors, for use in MOCVD techniques have a ligand of the general formula OCR | 07-28-2011 |
20120065383 | PROCESS FOR PRODUCING ORGANIC-MODIFIED INORGANIC FINE PARTICLES - A process is provided that includes performing a high-temperature high-pressure hydrothermal treatment for a reaction liquid prepared as a mixture of an acylated inorganic fine particle precursor and an organic modifying agent that has a carboxyl group. Because the reaction liquid contains the acylated inorganic fine particle precursor in advance, the grain growth during the high-temperature high-pressure hydrothermal treatment can be suppressed. The process thus enables production of organic-modified inorganic fine particles of a size about the same as or even smaller than that before the high-temperature high-pressure hydrothermal treatment. | 03-15-2012 |
20120130055 | METHOD FOR SYNTHESISING A RARE EARTH ORGANOPHOSPHATE AND USE THEREOF TO PREPARE A "PREFORMED" CATALYTIC SYSTEM - The invention relates to a process for preparing a rare-earth organophosphate in the form of a fluid or not very viscous solution that can be used as is for the preparation of a “preformed” catalyst system intended, in particular, for the cis-1,4 stereospecific polymerization of conjugated dienes. | 05-24-2012 |
20120142905 | Borohydride Metallocene Complex of a Lanthanide, Catalytic System Including Said Complex, Polymerization Method Using Same and Ethylene/Butadiene Copolymer Obtained Using Said Method - Borohydride metallocene complex of lanthanide, preparation process, catalytic system incorporating borohydride metallocene complex, process for copolymerization of olefins employing catalytic system. The complex corresponds to one or other of formulae A and B: | 06-07-2012 |
20120208989 | FLUORINATED AROMATIC MATERIALS AND THEIR USE IN OPTOELECTRONICS - Fluorinated aromatic materials, their synthesis and their use in optoelectronics. In some cases, the fluorinated aromatic materials are perfluoroalkylated aromatic materials that may include perfluoropolyether substituents. | 08-16-2012 |
20120238733 | PREPARATION OF CERIUM HALIDE SOLVATE COMPLEXES - Crystals of a solvated cerium(III) halide solvate complex resulted from a process of forming a paste of a cerium(III) halide in an ionic liquid, adding a solvent to the paste, removing any undissolved solid, and then cooling the liquid phase. Diffusing a solvent vapor into the liquid phase also resulted in crystals of a solvated cerium(III) halide complex. | 09-20-2012 |
20120329999 | PREPARATION OF LANTHANIDE-CONTAINING PRECURSORS AND DEPOSITION OF LANTHANIDE-CONTAINING FILMS - Methods and compositions for depositing rare earth metal-containing layers are described herein. In general, the disclosed methods deposit the precursor compounds comprising rare earth-containing compounds using deposition methods such as chemical vapor deposition or atomic layer deposition. The disclosed precursor compounds include a cyclopentadienyl ligand having at least one aliphatic group as a substituent and an amidine ligand. | 12-27-2012 |
20130090460 | RARE EARTH METAL COMPLEX - A rare earth metal complex including a rare earth element and a β-diketone compound represented by the following formula (1) as a ligand, and in formula (1), R | 04-11-2013 |
20130231468 | RARE EARTH METAL COMPLEX - Provided is a rare earth metal complex including a rare earth metal atom and a β-diketone compound coordinated to the rare earth metal atom, the β-diketone compound being represented by the following Formula (1). In Formula (1), R | 09-05-2013 |
20130281681 | Group 3 Post-Metallocene Complexes Based on Bis(Naphthoxy)Pyridine and Bis(Naphthoxy)ThioPhene Ligands for the Ring-Opening Polymerisation of Polar Cyclic Monomers - The present invention relates to the use of group 3 post-metallocene complexes based on sterically encumbered bis(naphthoxy)pyridine and bis(naphthoxy)thiophene ligands in the ring-opening polymerisation of polar monomers such as, for examples, lactones, lactides, cyclic carbonates. | 10-24-2013 |
20130303739 | PREPARATION OF LANTHANIDE-CONTAINING PRECURSORS AND DEPOSITION OF LANTHANIDE-CONTAINING FILMS - Methods and compositions for depositing rare earth metal-containing layers are described herein. In general, the disclosed methods deposit the precursor compounds comprising rare earth-containing compounds using deposition methods such as chemical vapor deposition or atomic layer deposition. The disclosed precursor compounds include a cyclopentadienyl ligand having at least one aliphatic group as a substituent and an amidine ligand. | 11-14-2013 |
20130310547 | RARE EARTH METAL COMPLEX - Provided is a rare earth metal complex including a rare earth metal atom and a β-diketone compound coordinated to the rare earth metal atom, the β-diketone compound being represented by the following Formula (1). In Formula (1), R represents a monovalent aromatic hydrocarbon group or a monovalent aromatic heterocyclic group. | 11-21-2013 |
20140011985 | Targeted Cancer Therapy Conjugates Using Porphyrins and Porphyrin-like Molecules and Various Cytotoxic Agents - Disclosed are targeted in-vivo cancer therapeutics based on the creating conjugate combinations of a porphyrin or porphyrin-like molecule or compound used as a delivery vehicle or vector, coupled with a cytotoxic agent that is released upon binding to a tumor site. The families of porphyrin or porphyrin-like molecules or compounds have a high affinity to bind with cancer cells and are organic structures and are not toxic or rejected by the body. The structure includes a binding site for metals and nano-particles. Benefits of the current invention include: accurate, targeted in-vivo radio and therapeutic agents delivered directly to tumor sites. A benefit of targeted therapy is sparing healthy cells and tissue, thus keeping the host patient healthier which enhances the therapeutic effects of reducing and destroying the cancer tumors. An additional benefit is keeping the patient from discomfort of sickness and the side effects of traditional radio and chemo-therapies. | 01-09-2014 |
20140213777 | LUMINESCENT PROBES FOR BIOLOGICAL LABELING AND IMAGING, AND PROCESS FOR PREPARING THE SAME - The present invention relates to organic compounds, usable as ligands in the preparation of lanthanide complexes or of certain water-soluble transition metals, a method for preparation thereof, and the use of said organic compounds as fluorescent probes. | 07-31-2014 |
20150336092 | COMPOSITIONS COMPRISING FUNCTIONALIZED CARBON-BASED NANOSTRUCTURES AND RELATED METHODS - The present invention generally relates to compositions comprising and methods for forming functionalized carbon-based nanostructures. | 11-26-2015 |
20160024617 | METHODS FOR GAS-PHASE THERMOCHROMATOGRAPHIC SEPARATIONS OF FISSION AND ACTIVATION PRODUCTS - Methods are provided for characterizing samples containing chemical elements such as rare earth elements, actinides, and heavy transition metals by treating the samples to form volatile complexes of the elements (e.g., β-diketonate complexes or other organic ligand complexes of the elements) and then analyzing the complexes, for example, via gas-phase thermochromatography. Also provided are methods for separating and/or recovering such chemical elements. The methods produce less waste and can be performed more rapidly than conventional liquid extraction methods and can provide separated elements of high purity (e.g., 99.9999% purity). | 01-28-2016 |
20160145273 | PRECATALYST FOR SHIBASAKI'S RARE EARTH METAL BINOLATE CATALYSTS - Disclosed herein are schemes for the synthesis of novel hydrogen-bonded rare earth-BINOLate precatalyst complexes, the precatalysts, per se, and their application for the generation of anhydrous REMB catalysts by cation-exchange from metal halides. | 05-26-2016 |
20160160121 | SHEET INTEGRATED RARE EARTH COMPLEX AND USE THEREOF - Provided are: a rare earth complex which has a novel structure, which exhibits compatibility with organic solvents and resins, and which exhibits excellent luminescent properties as a luminescent element; and a use thereof. This rare earth complex includes: a phosphine oxide compound represented by general formula (1); at least one rare earth ion selected from the group consisting of Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, and Lu; and a ligand compound. In the rare earth complex, the coordination numbers of the ligand compound and the phosphine oxide compound represented by general formula (1) to the rare earth ion are 8-10, and a plurality of the phosphine oxide compounds represented by general formula (1) and a plurality of the rare earth ions are provided with a crosslinked structure. | 06-09-2016 |
534016000 | Containing -C(=X)X-, wherein the X's are the same or diverse chalcogens | 19 |
20080227962 | Method for Obtaining Highly Luminescent Lanthanide Complexes - The invention concerns a transition metal coordination complex of general formula (I) {[M(X)]C(H | 09-18-2008 |
20080300387 | Organometallic Framework Materials of Transition Group III - The present invention relates to a process for preparing a porous metal organic framework, which comprises the step: | 12-04-2008 |
20090131643 | Rapid metal organic framework molecule synthesis method - A rapid, simple and versatile metal organic framework molecule (MOF) synthesis method particularly adapted to make non-linear MOFs includes heating MOF precursors, such as a metal or metal oxide and an organic ligand, in a microwave oven for a period sufficient to achieve crystallization. Microwave-assisted MOF synthesis yields high quality MOF crystals in a reaction time ranging from about 5 seconds to about 2.5 minutes, compared to hours and days required in conventional solvothermal and hydrothermal methods. In addition, microwave assisted methods provide MOF materials with uniform crystal size and well-defined shape. Further, microwave synthesis of MOFs allows the size and shape of MOF crystals to be tailored for use in a wide range applications by manipulating reaction conditions. Secondary growth processes may also be employed to grow larger crystals using seeds obtained from microwave-assisted synthesis methods. | 05-21-2009 |
20090270600 | SILICA PARTICLE COMPRISING AN ORGANOLANTHANIDE COMPOUND, PREPARATION PROCESS THEREFOR AND USES THEREOF - The present invention relates to a silica particle comprising at least one complex of at least one lanthanide and of at least one ligand of formula (A) | 10-29-2009 |
20100081799 | Chelating Agent - A compound of the formula: wherein R | 04-01-2010 |
20100190967 | Method of Dynamic Nuclear Polarisation (DNP) and Compounds and Compositions for Use in the Method - The invention relates to an improved method of dynamic nuclear polarisation (DNP) of carboxylic acids and to compounds and compositions for use in the method. | 07-29-2010 |
20110065905 | Ligand and metal complex - A ligand of Formula (I) is provided: | 03-17-2011 |
20110294992 | METAL RESPONSIVE MRI-AGENTS - The present invention provides compositions comprising an MRI contrast agent and methods of their use. | 12-01-2011 |
20120029177 | HETEROCYCLE-AMINO ACID DERIVATIVES FOR TARGETING CANCER TISSUE AND RADIOACTIVE OR NON-RADIOACTIVE LABELED COMPOUNDS THEREOF - The present invention relates to novel amino acid derivatives containing heterocyclic chelating residues thereof; radioactive or nonradioactive metal complexes thereof; methods for preparation thereof; and apyrogenic and sterile preparative kits of the composition for targeting cancer cells. | 02-02-2012 |
20120065384 | FLUORESCENT MRI PROBE - A fluorescent gadolinium complex compound comprising a residue of gadolinium.1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid or a residue of gadolinium.diethylenetriaminepentaacetic acid bound covalently with a group represented by the following general formula (I) (R | 03-15-2012 |
20120245333 | PROCESS FOR THE PREPARATION OF CHELATED COMPOUND - The present invention generally relies on a process for the preparation of chelated compounds, comprising the selective interaction between a solid matrix and a chelating agent. In more details, the present invention enables the preparation of chelated compounds useful as diagnostic agents, in high yields and in a reliable way. | 09-27-2012 |
20130079503 | GO-GD-DTPA COMPLEX, PREPARATION METHOD THEREOF, AND MRI CONTRAST AGENT COMPRISING THE SAME - Disclosed herein is a GO-Gd-DTPA (gadolinum-diethylenetriamine pentaacetic-graphene oxide) complex, which is formed by an ester bond of graphene oxide (GO) and gadopentetic acid (Gd-DTPA). Since the GO-Gd-DTPA can stably exist in the body because it has high stability in water, it is expected that it can be effectively used as an MRI contrast agent. | 03-28-2013 |
20130158241 | Process for Preparing Crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic Acid and Use for Production of Primovist.RTM. - The invention relates to a method for producing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid of the formula I | 06-20-2013 |
20130296539 | MAGNETIC RESONANCE IMAGING AGENTS FOR CALCIFICATION - The present invention discloses magnetic resonance compatible contrast agents for water-poor structures, such as bone and tissue calcification. In particular, the present invention discloses bisphosphonate-based magnetic resonance imaging contrast agents specific for hydroxyapatite, the calcium salt most commonly associated with malignant calcification. | 11-07-2013 |
20140005369 | URIDINE-BASED GADOLINIUM COMPLEX AND MRI CONTRAST AGENT INCLUDING THE SAME | 01-02-2014 |
20140058072 | MULTIMERIC PEPTIDOMIMETIC FIBROSIS SPECIFIC DUAL-MODALITY PROBES - The present invention describes dual-modality probes. In particular, the present invention discloses fibrosis specific multimeric small-molecule peptidomimetic dual-modality MRI and optical probes. | 02-27-2014 |
20140058073 | RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND - The present invention provides a rare earth metal complex represented by the following formula (I). | 02-27-2014 |
20140107325 | PREPARATION OF HIGH-PURITY GADOBUTROL - What is described is a process for producing high-purity gadobutrol in a purity (according to HPLC) of more than 99.7 or 99.8 or 99.9% and the use for preparing a pharmaceutical formulation for parenteral administration. The process is carried out using specifically controlled crystallization conditions. The more recent developments in the field of the gadolinium-containing MR contrast agents (EP 0448191 B1, CA Patent 1341176, EP 0643705 B1, EP 0986548 B1, EP 0596586 B1) include the MRT contrast agent gadobutrol (Gadovist® 1.0) which has been approved for a relatively long time in Europe and more recently also in the USA under the name Gadavist®. | 04-17-2014 |
20140171627 | MULTIMERIC BIOTINIDASE RESISTANT MULTIMODALITY PROBES - The present invention describes multimeric multimodality probes. In particular, the present invention discloses (strept)avidin specific multimeric biotinidase resistant multimodality probes. | 06-19-2014 |